Background: MicroRNA-210 (miR-210) is an oncogenic miRNA previously associated with
prognosis in human gliomas, an incurable tumour type of the central nervous system. Here …

Abstract MicroRNA-210 (miR-210) levels are elevated in many tumor types, are frequently
associated with hypoxia induction, and are correlated with poor prognosis in many solid …

OBJECT Circulating microRNAs (miRNAs) are a new class of highly promising cancer
biomarkers. Malignant glioma is one of the most devastating and lethal forms of intrinsic …

Abstract microRNAs (miRNAs) are a class of small non-coding RNAs, approximately 21–25
nucleotides in length. Recently, some researchers have demonstrated that plasma miRNAs …

Objective Glioblastoma (GBM) is the most common primary malignant neoplasm of the
central nervous system (CNS). Despite the progress in therapeutic strategies such as …

Biomarkers in blood have become increasingly appreciated in the diagnosis of glioma, but
most of their diagnostic accuracy was not high enough to be used widely in a clinical …

Background: MicroRNAs are proposed as plasma biomarkers in cancer. Glioblastoma is the
most frequent primary brain tumor of adults. MicroRNA-21 was shown to induce …

Background Previous studies showed the aberrant expression of microRNA-182 (miR-182)
in glioma tissue. However, the exact role of circulating miR-182 in glioma remains unclear …

Objective Glioblastoma multiforme (GBM) is a highly malignant brain tumor with a poor
prognosis. MicroRNAs (miRNAs) are a class of small non-coding RNAs, approximately 21 …

BACKGROUND: MicroRNA (miR)-376 family play crucial roles in cancer formation and
progression. OBJECTIVE: To investigate expression patterns of circulating miR-376 …